GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioneer Corp (XKRX:064550) » Definitions » Research & Development

Bioneer (XKRX:064550) Research & Development : ₩15,031 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Bioneer Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bioneer's Research & Development for the three months ended in Dec. 2023 was ₩5,234 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩15,031 Mil.


Bioneer Research & Development Historical Data

The historical data trend for Bioneer's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioneer Research & Development Chart

Bioneer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,984.75 13,118.12 17,986.72 16,751.11 15,031.34

Bioneer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,952.73 3,958.52 1,484.80 4,354.29 5,233.73

Bioneer Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩15,031 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioneer  (XKRX:064550) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Bioneer Research & Development Related Terms

Thank you for viewing the detailed overview of Bioneer's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioneer (XKRX:064550) Business Description

Traded in Other Exchanges
N/A
Address
8-11, Munpyeongseoro, Daedeok-Gu, Daejeon, South Chungcheong, KOR, 306-220
Bioneer Corp engages in the manufacture and sale of biotechnological products in South Korea. It offers deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits, DNA and ribonucleic acid (RNA) amplification products, human diagnostics kits, veterinary diagnostics kits, among others.

Bioneer (XKRX:064550) Headlines

No Headlines